IPXL Insider Trading Activity and SEC Form 4 Filings
IPXL insider trading summary
No open-market insider purchases or sales of Impax Laboratories Inc (IPXL) have been reported on SEC Form 4 in the past 12 months.
Latest IPXL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 31, 2017 | Michael Nestor | President, Impax Specialty | Sell | $17K (1,130 @ $15.00) |
| May 17, 2017 | Michael Nestor | President, Impax Specialty | Sell | $14K (857 @ $16.48) |
| May 12, 2017 | Michael Nestor | President, Impax Specialty | Sell | $12K (700 @ $17.11) |
| Aug 15, 2016 | Leslie Z Benet | Director | Sell | $230K (10,092 @ $22.81) |
| Sep 11, 2015 | Mark A Schlossberg | SVP and General Counsel | Sell | $323K (7,457 @ $43.30) |
| Sep 10, 2015 | Michael Nestor | President, Impax Pharm. | Sell | $218K (5,000 @ $43.56) |
| Aug 31, 2015 | Nigel Fleming | Director | Sell | $410K (10,000 @ $41.02) |
| Aug 31, 2015 | Nigel Fleming | Director | Sell | $253K (6,166 @ $41.02) |
| Aug 31, 2015 | Michael Markbreiter | Director | Sell | $414K (10,000 @ $41.39) |
| Aug 31, 2015 | Leslie Z Benet | Director | Sell | $123K (3,000 @ $40.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.